Skip to main content

Table 1 Patient and tumor characteristics

From: Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients

 

n, median (min–max)

%

Sex

Male

64

59.3

Female

44

40.7

Age (years)

41 (22–87)

 

< 41

53

49.1

≥ 41

55

50.9

KPS (%)

90 (60–100)

 

< 90

25

23.1

≥ 90

69

63.9

Unknown

14

13.0

IDH

Mutant

84

77.8

Wildtype

9

8.3

Unknown

15

13.9

MGMT

Methylated

86

79.6

Non-methylated

19

17.6

Unknown

3

2.8

1p/19q-Codeletion

Non-codeleted

108

100.0

Codeleted

0

0.0

Unknown

0

0.0

Resection

Biopsy

13

12.0

Subtotal resection

25

23.1

Gross total resection

65

60.2

Unknown

5

4.6

Treatment after surgery

CTx mono

48

44.4

RT mono

8

7.4

RT + concCTx

5

4.6

RT + adjCTx

5

4.6

RT + concCTx + adjCTx

20

18.5

RT, CTx unknown

6

5.6

No RT, CTx unknown

3

2.8

Unknown

13

12.0

  1. KPS Karnofsky performance status, IDH isocitrate dehydrogenase type 1 and 2, MGMT O6-methylguanine-DNA-methyltransferase, CTx chemotherapy, RT radiotherapy, concCTx concomitant chemotherapy, adjCTx adjuvant chemotherapy